FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4239951311> ?p ?o ?g. }

• W4239951311 endingPage "58" @default.
• W4239951311 startingPage "45" @default.
• W4239951311 abstract "Previous in vivo studies from several laboratories had shown remarkable curative effect of methylglyoxal on cancer-bearing animals. In contrast, most of the recent in vitro studies have assigned a toxic role for methylglyoxal. The present study was initiated with the objective to resolve whether methylglyoxal is truly toxic in vivo and to reassess its therapeutic potential. Four species of animals, both rodent and non-rodent, were treated with different doses of methylglyoxal through oral, subcutaneous and intravenous routes. Acute (treatment for only 1 day) toxicity tests had been done with mouse and rat. These animals received 2, 1 and 0.3 g of methylglyoxal/kg of body weight in a day through oral, subcutaneous and intravenous routes respectively. Chronic (treatment for around a month) toxicity test had been done with mouse, rat, rabbit and dog. Mouse, rat and dog received 1, 0.3 and 0.1 g of methylglyoxal/kg of body weight in a day through oral, subcutaneous and intravenous routes respectively. Rabbit received 0.55, 0.3 and 0.1 g of methylglyoxal/kg of body weight in a day through oral, subcutaneous and intravenous routes respectively. It had been observed that methylglyoxal had no deleterious effect on the physical and behavioral pattern of the treated animals. Fertility and teratogenecity studies were done with rats that were subjected to chronic toxicity tests. It had been observed that these animals produced healthy litters indicating no damage of the reproductive systems as well as no deleterious effect on the offspring. Studies on several biochemical and hematological parameters of methylglyoxal-treated rats and dogs and histological studies of several organs of methylglyoxal-treated mouse were performed. These studies indicated that methylglyoxal had no apparent deleterious effect on some vital organs of these animals. A detailed pharmacokinetic study was done with mouse after oral administration of methylglyoxal. The effect of methylglyoxal alone and in combination with creatine and ascorbic acid on cancer-bearing animals had been investigated by measuring the increase in life span and tumor cell growth inhibition. The results indicated that anticancer effect of methylglyoxal was significantly augmented by ascorbic acid and further augmented by ascorbic acid and creatine. Nearly 80% of the animals treated with methylglyoxal plus ascorbic acid plus creatine were completely cured and devoid of any malignant cells within the peritoneal cavity." @default.
• W4239951311 created "2022-05-12" @default.
• W4239951311 creator A5005955210 @default.
• W4239951311 creator A5035877423 @default.
• W4239951311 creator A5044141575 @default.
• W4239951311 creator A5045855363 @default.
• W4239951311 creator A5047301459 @default.
• W4239951311 creator A5050484829 @default.
• W4239951311 date "2006-04-01" @default.
• W4239951311 modified "2023-10-05" @default.
• W4239951311 title "In vivo assessment of toxicity and pharmacokinetics of methylglyoxal" @default.
• W4239951311 cites W118324404 @default.
• W4239951311 cites W1528840891 @default.
• W4239951311 cites W1611640819 @default.
• W4239951311 cites W1631973292 @default.
• W4239951311 cites W1776564239 @default.
• W4239951311 cites W1973924126 @default.
• W4239951311 cites W1997939158 @default.
• W4239951311 cites W1999493479 @default.
• W4239951311 cites W2000228729 @default.
• W4239951311 cites W2025967280 @default.
• W4239951311 cites W2029136090 @default.
• W4239951311 cites W2034484030 @default.
• W4239951311 cites W2037066522 @default.
• W4239951311 cites W2050886496 @default.
• W4239951311 cites W2051786840 @default.
• W4239951311 cites W2055081817 @default.
• W4239951311 cites W2061895500 @default.
• W4239951311 cites W2061968178 @default.
• W4239951311 cites W2068418661 @default.
• W4239951311 cites W2073195938 @default.
• W4239951311 cites W2091103817 @default.
• W4239951311 cites W2092263511 @default.
• W4239951311 cites W2097792751 @default.
• W4239951311 cites W2109028819 @default.
• W4239951311 cites W2162234541 @default.
• W4239951311 cites W28486177 @default.
• W4239951311 cites W4241290457 @default.
• W4239951311 doi "https://doi.org/10.1016/j.taap.2005.07.003" @default.
• W4239951311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16112157" @default.
• W4239951311 hasPublicationYear "2006" @default.
• W4239951311 type Work @default.
• W4239951311 citedByCount "59" @default.
• W4239951311 countsByYear W42399513112012 @default.
• W4239951311 countsByYear W42399513112014 @default.
• W4239951311 countsByYear W42399513112015 @default.
• W4239951311 countsByYear W42399513112016 @default.
• W4239951311 countsByYear W42399513112017 @default.
• W4239951311 countsByYear W42399513112018 @default.
• W4239951311 countsByYear W42399513112019 @default.
• W4239951311 countsByYear W42399513112020 @default.
• W4239951311 countsByYear W42399513112021 @default.
• W4239951311 countsByYear W42399513112022 @default.
• W4239951311 countsByYear W42399513112023 @default.
• W4239951311 crossrefType "journal-article" @default.
• W4239951311 hasAuthorship W4239951311A5005955210 @default.
• W4239951311 hasAuthorship W4239951311A5035877423 @default.
• W4239951311 hasAuthorship W4239951311A5044141575 @default.
• W4239951311 hasAuthorship W4239951311A5045855363 @default.
• W4239951311 hasAuthorship W4239951311A5047301459 @default.
• W4239951311 hasAuthorship W4239951311A5050484829 @default.
• W4239951311 hasConcept C112705442 @default.
• W4239951311 hasConcept C126322002 @default.
• W4239951311 hasConcept C150903083 @default.
• W4239951311 hasConcept C167552308 @default.
• W4239951311 hasConcept C181199279 @default.
• W4239951311 hasConcept C207001950 @default.
• W4239951311 hasConcept C2776390293 @default.
• W4239951311 hasConcept C2778592357 @default.
• W4239951311 hasConcept C29730261 @default.
• W4239951311 hasConcept C42407357 @default.
• W4239951311 hasConcept C55493867 @default.
• W4239951311 hasConcept C71924100 @default.
• W4239951311 hasConcept C86803240 @default.
• W4239951311 hasConcept C98274493 @default.
• W4239951311 hasConceptScore W4239951311C112705442 @default.
• W4239951311 hasConceptScore W4239951311C126322002 @default.
• W4239951311 hasConceptScore W4239951311C150903083 @default.
• W4239951311 hasConceptScore W4239951311C167552308 @default.
• W4239951311 hasConceptScore W4239951311C181199279 @default.
• W4239951311 hasConceptScore W4239951311C207001950 @default.
• W4239951311 hasConceptScore W4239951311C2776390293 @default.
• W4239951311 hasConceptScore W4239951311C2778592357 @default.
• W4239951311 hasConceptScore W4239951311C29730261 @default.
• W4239951311 hasConceptScore W4239951311C42407357 @default.
• W4239951311 hasConceptScore W4239951311C55493867 @default.
• W4239951311 hasConceptScore W4239951311C71924100 @default.
• W4239951311 hasConceptScore W4239951311C86803240 @default.
• W4239951311 hasConceptScore W4239951311C98274493 @default.
• W4239951311 hasIssue "1" @default.
• W4239951311 hasLocation W42399513111 @default.
• W4239951311 hasLocation W42399513112 @default.
• W4239951311 hasOpenAccess W4239951311 @default.
• W4239951311 hasPrimaryLocation W42399513111 @default.
• W4239951311 hasRelatedWork W1491964893 @default.
• W4239951311 hasRelatedWork W1998587742 @default.
• W4239951311 hasRelatedWork W2004556784 @default.
• W4239951311 hasRelatedWork W2094219250 @default.

• next